SCHEMBL5887188

SCHEMBL5887188

Cc1ccc(C2=CC[CH]C(Cl)=C2c2ccc(C(F)(F)F)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.33
KDM1A O60341 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
CYP2C19 P33261 1/20 0.33
HSD17B10 Q99714 1/20 0.33
NPBWR1 P48145 1/20 0.33
KIF11 P52732 5/20 0.33
BACE1 P56817 1/20 0.33
PAX8 Q06710 1/20 0.32
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32
RAD51 Q06609 1/20 0.32
CYP1A1 P04798 1/20 0.31
CYP1B1 Q16678 1/20 0.31
TP53 P04637 1/20 0.31
POLB P06746 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5886998 0.80 ALDH1A1 (0.33) ALDH1A1KDM1ACYP2D6CYP2C9HPGD
SCHEMBL5887126 0.77 ALKBH3 (0.42) ALDH1A1CYP2D6CYP2C9HPGDALOX15
SCHEMBL5887164 0.77 ALDH1A1 (0.35) ALDH1A1KDM1ANPBWR1KIF11BACE1
SCHEMBL5887450 0.75 KIF11 (0.36) ALDH1A1KDM1ANPBWR1KIF11BACE1
SCHEMBL4013100 0.74 ESR2 (0.39) CYP2C9CYP2C19ESR2TP53GAA
SCHEMBL5887446 0.72 ALKBH3 (0.39) RAD51CYP1B1
SCHEMBL5887471 0.72 KIF11 (0.34) ALDH1A1KDM1AHPGDNPBWR1KIF11
SCHEMBL13019482 0.70 KIF11 (0.61) ALDH1A1NPBWR1KIF11CYP1A1CYP1B1
SCHEMBL17110032 0.70 KIF11 (0.61) ALDH1A1NPBWR1KIF11CYP1A1CYP1B1
SCHEMBL1044865 0.70 KIF11 (0.61) ALDH1A1NPBWR1KIF11CYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7037931-B2 Corticotropin releasing factor moderator; analgesics; drug abruse, drug dependency; schizophrenia JANSSEN PHARMACEUTICA N.V. (BE) 2006-05-02 US disclosed
US-20050026903-A1 CCK-1 receptor modulators JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050026903-A1 CCK-1 receptor modulators CCKAR, CCKBR, GLP1R ALDH1A1 1501/4885KDM1A 1089/4885CYP2D6 1004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.